Is targeted therapy possible for patients with gastric adenocarcinoma?

被引：1
|
作者：
Kaya, Dilsa Mizrak [1 ]
Harada, Kazuto [1 ]
Ajani, Jaffer A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd,FC10-3022, Houston, TX 77030 USA
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2016年 / 17卷 / 18期
关键词：
DOUBLE-BLIND; CANCER;
D O I：
10.1080/14656566.2016.1236917
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2371 / 2374
页数：4
相关论文
共 50 条
  • [41] Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy - An Update
    Woell, Ewald
    Amann, Arno
    Eisterer, Wolfgang
    Gerger, Armin
    Gruenberger, Birgit
    Rumpold, Holger
    Weiss, Lukas
    Winder, Thomas
    Greil, Richard
    Prager, Gerald W.
    ANTICANCER RESEARCH, 2023, 43 (07) : 2889 - 2897
  • [42] Evaluation of PET response to neoadjuvant therapy for patients with gastric and GEJ adenocarcinoma.
    Hernandez, Jonathan M.
    Beylergil, Volkan
    Goldman, Debora
    Schoeder, Heiko
    Gonen, Mithat
    Tang, Laura H.
    Downey, Robert J.
    Shah, Manish A.
    Strong, Vivian E.
    Coit, Daniel G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [43] Targeted therapies of HER2-positive gastric adenocarcinoma
    Schulze, Arik Bernard
    Kerkhoff, Andrea
    Lenz, Georg
    Kessler, Torsten
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S177 - S180
  • [44] Targeted Therapy Followed by Cytotoxic Chemotherapy in Preoperative Patients With Locally Advanced Lung Adenocarcinoma
    Aoki, Masaya
    Ueda, Kazuhiro
    Umehara, Tadashi
    Kamimura, Go
    Tokunaga, Takuya
    Harada-Takeda, Aya
    Maeda, Koki
    Nagata, Toshiyuki
    Yokomakura, Naoya
    Kariatsumari, Kota
    Nonaka, Yuto
    Imamura, Nobuhiro
    Morizono, Shoichiro
    Sato, Masami
    ANTICANCER RESEARCH, 2020, 40 (05) : 2911 - 2916
  • [45] Loss of PTEN Immunohistochemical Expression in Patients with Advanced Colorectal Adenocarcinoma: Implications for Targeted Therapy
    Bakkar, R.
    Broaddus, R.
    LABORATORY INVESTIGATION, 2012, 92 : 154A - 155A
  • [46] A model for defining molecular aspects of pancreatic ductal adenocarcinoma patients for targeted adjuvant therapy
    Showalter, Shayna L.
    Witkiewicz, Agnes
    Cozzitorto, Joseph A.
    Sauter, Patricia K.
    Kennedy, Eugeen P.
    Yeo, Charles J.
    Brody, Jonathan R.
    GASTROENTEROLOGY, 2008, 134 (04) : A913 - A913
  • [47] Loss of PTEN Immunohistochemical Expression in Patients with Advanced Colorectal Adenocarcinoma: Implications for Targeted Therapy
    Bakkar, R.
    Broaddus, R.
    MODERN PATHOLOGY, 2012, 25 : 154A - 155A
  • [48] Concomitant genetic alterations are associated with response to EGFR targeted therapy in patients with lung adenocarcinoma
    Chen, Hualin
    Liu, Meilian
    Dai, Zhiwei
    Li, Shujun
    Luo, Yiping
    Wang, Yongcun
    Su, Wenmei
    Cai, Weijing
    Yang, Donghong
    Huang, Jian
    Yang, Zhixiong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1225 - 1234
  • [49] The one year survival rate of lung adenocarcinoma patients treated with chemotherapy or targeted therapy
    Rusdi, Fidiyah
    Iskandar, Harun
    Hardjianti, Tutik
    Bakri, Syakib
    Udaya, Wasis
    Kasim, Hasyim
    Arief, Erwin
    Seweng, Arifin
    ENFERMERIA CLINICA, 2020, 30 : 456 - 460
  • [50] Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy
    Norollahi, Syedeh Elham
    Mansour-Ghanaei, Fariborz
    Joukar, Farahnaz
    Ghadarjani, Shervin
    Mojtahedi, Kourosh
    Nejad, Kaveh Gharaei
    Hemmati, Hossein
    Gharibpoor, Faeze
    Khaksar, Roya
    Samadani, Ali Akbar
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 115
12345